Shifting the Paradigm: A Population Health Approach to the Management of Direct Oral Anticoagulants.
Arthur L AllenJessica LucasDavid ParraPatrick SpoutzJeffery L KibertBishoy RaghebLinda ChiaAmy SipePublished in: Journal of the American Heart Association (2021)
Over the past decade, direct oral anticoagulants (DOACs) have contributed to a major paradigm shift in thrombosis management, replacing vitamin K antagonists as the most commonly prescribed anticoagulants in many countries. While DOACs provide distinct advantages over warfarin (eg, convenience, simplicity, and safety), they are frequently associated with inappropriate prescribing and adverse events. These events have prompted regulatory agencies to mandate oversight, which individual institutions may find difficult to comply with given limited resources. Veterans Health Administration (VHA) has leveraged technology to develop the DOAC Population Management Tool (PMT) to address these challenges. This tool has empowered VHA to update a 60-year standard of care from one-to-one provider-to-patient anticoagulation monitoring to a population-based management approach. The DOAC PMT allows for the oversight of all patients prescribed DOACs and leads to intervention only when clinically indicated. Using the DOAC PMT, facilities across VHA have maximized DOAC oversight while minimizing resource usage. Herein, we discuss how the DOAC PMT was conceived, developed, and implemented, along with the challenges encountered throughout the process. Additionally, we share the impact of the DOAC PMT across VHA, and the potential of this approach beyond anticoagulation and VHA.
Keyphrases
- direct oral anticoagulants
- venous thromboembolism
- atrial fibrillation
- primary care
- healthcare
- randomized controlled trial
- public health
- mental health
- end stage renal disease
- pulmonary embolism
- ejection fraction
- newly diagnosed
- palliative care
- human health
- emergency department
- oral anticoagulants
- quality improvement
- climate change
- pain management
- patient reported outcomes
- electronic health record
- adverse drug